Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 80
Filter
1.
Transpl Infect Dis ; 8(4): 203-12, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17116133

ABSTRACT

We have retrospectively analyzed the incidence of cytomegalovirus (CMV) infection in 250 consecutive renal allograft transplants performed in 244 recipients. The mean follow-up was 35.1+/-25.4 months. Immunosuppression was cyclosporine- or tacrolimus-based triple therapy. CMV infection prophylaxis with ganciclovir for 3 months post transplant was prescribed in CMV-seronegative recipients of allografts from seropositive donors (D+R-) and in all recipients treated with OKT3. CMV antigenemia was monitored by the pp65-antigen assay. Thirteen of 57 D+R- recipients (22.8%) developed CMV antigenemia. One recipient had a breakthrough of CMV antigenemia during ganciclovir prophylaxis; 12 D+R- recipients developed CMV antigenemia 147.5+/-173.8 days after transplantation. Four of 13 (30.7%) D+R- recipients had asymptomatic CMV infection, 8 (61.6%) had CMV infection with non-specific symptoms including fever, and 1 (7.7%) developed CMV pneumonia. Six of 13 (46.1%) D+R- patients had been treated with intensified immunosuppressive therapy before CMV infection. In the low-risk CMV groups (D+R+; D-R+; D-R-), 28 recipients (14.5%) developed CMV antigenemia 42.5+/-15.2 days post transplantation. Ten of the 28 (35.7%) recipients had asymptomatic CMV infection, 17 (60.7%) developed CMV infection with non-specific symptoms, and 1 (3.6%) developed CMV pneumonia. Twenty-one of 28 (75.0%) had intensified immunosuppressive therapy before CMV infection. In conclusion, ganciclovir prophylaxis diminished and delayed the onset of CMV infection but did not totally prevent it from occurring in D+R- renal transplant recipients. Clinicians should be vigilant to the possibility of CMV infection in both seronegative and seropositive recipients, especially after anti-rejection therapy.


Subject(s)
Cytomegalovirus Infections/etiology , Kidney Transplantation , Adult , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/immunology , Female , Ganciclovir/therapeutic use , HLA-DR Antigens/immunology , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Retrospective Studies
2.
Cochrane Database Syst Rev ; (4): CD004080, 2006 Oct 18.
Article in English | MEDLINE | ID: mdl-17054196

ABSTRACT

BACKGROUND: The role of early postoperative enteral nutrition after gastrointestinal surgery is controversial. Traditional management consist of 'nil by mouth', where patients receive fluids followed by solids when tolerated. Although several trials have implicated lower incidence of septic complications and faster wound healing upon early enteral feeding, other trials have shown opposite results. The immediate advantage of caloric intake could be a faster recovery with fewer complications, to be evaluated systematically. OBJECTIVES: To evaluate whether early commencement of postoperative enteral nutrition compared to traditional management (no nutritional supply) is associated with fewer complications in patients undergoing gastrointestinal surgery SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials, PUBMED, EMBASE, and LILACS from 1979 (first RCT published) to March 2006. We manually scanned the references from the relevant articles, and consulted primary authors for additional information. SELECTION CRITERIA: We looked for randomised controlled trials (RCT's) comparing early commencement of feeding (within 24 hours) with no feeding in patients undergoing gastrointestinal surgery. Early enteral nutrition is defined as all oral intakes (i.e. registered oral intake, supplemented oral feeding) and any kind of tube feeding (gastric, duodenal or jejunal) containing caloric content. No feeding is traditional management, defined as none caloric oral intake or any kind of tube feeding before bowel function. The definition 'no nutrition' includes non caloric placebo and water. DATA COLLECTION AND ANALYSIS: The three authors independently assessed the identified trials, and extracted the relevant data using a specifically developed data extraction sheet. Primary end points of interest were: Wound infections and intraabdominal abscesses, postoperative complications such as acute myocardial infarction, postoperative thrombosis or pneumonia, anastomotic leakages, mortality, length of hospital stay, and significant adverse effects. We combined data to estimate the common relative risk of postoperative complications, and calculated the associated 95% confidence intervals. For analysis, we used fixed effects model (risk ratios to summarise the treatment effect) whenever feasible. The treatment effect on length of stay was estimated using effect size (presented as mean +/- SD). Some outcomes were not analysed but presented in a descriptive way. We used a random effects model to estimate overall risk ratio and effect size. MAIN RESULTS: We identified thirteen randomised controlled trials, with a total of 1173 patients, all undergoing gastrointestinal surgery. Individual clinical complications failed to reach statistical significance, but the direction of effect indicates that earlier feeding may reduce the risk of post surgical complications. Mortality was the only outcome showing a significant benefit, but not necessarily associated with early commencement of feeding, as the reported cause of death was anastomotic leakage, reoperation, and acute myocardial infarction. AUTHORS' CONCLUSIONS: Although non-significant results, there is no obvious advantage in keeping patients 'nil by mouth' following gastrointestinal surgery, and this review support the notion on early commencement of enteral feeding.


Subject(s)
Colon/surgery , Enteral Nutrition , Postoperative Complications/therapy , Rectum/surgery , Humans , Randomized Controlled Trials as Topic , Time Factors
3.
Cochrane Database Syst Rev ; (3): CD001439, 2005 Jul 20.
Article in English | MEDLINE | ID: mdl-16034862

ABSTRACT

BACKGROUND: Appendicitis is the most common cause of acute abdominal pain requiring surgical intervention. The cause of appendicitis is unclear and the mechanism of pathogenesis continues to be debated. Despite improved asepsis and surgical techniques, postoperative complications, such as wound infection and intraabdominal abscess, still account for a significant morbidity. Several studies implicate that postoperative infections are reduced by administration of antimicrobial regimes. OBJECTIVES: This review evaluated the use of antibiotics compared to placebo or no treatment in patients undergoing appendectomy. Will these patients benefit from antimicrobial prophylaxis? The outcomes were described according to the nature of the appendix, as either simple appendicitis (including the non-infectious stage) and complicated appendicitis. The efficacy of different antibiotic regimens were not evaluated. SEARCH STRATEGY: We searched The Cochrane Central Register of Controlled Trials (Cochrane Library 2005 issue 1); Pubmed ; EMBASE; and the Cochrane Colorectal Cancer Group Specialised Register (April 2005). In addition, we manually searched the reference lists of the primary identified trials. SELECTION CRITERIA: We evaluated Randomised Controlled Trials (RCTs) and Controlled Clinical Trials (CCTs) in which any antibiotic regime were compared to placebo in patients suspected of having appendicitis, and undergoing appendectomy. Both studies on children and adults were reviewed. The outcome measures of the studies were: Wound infection, intra abdominal abscess, length of stay in hospital, and mortality. DATA COLLECTION AND ANALYSIS: Eligibility and trial quality were assessed, recorded and cross-checked by two reviewers. MAIN RESULTS: Forty-five studies including 9576 patients were included in this review. The overall result is that the use of antibiotics is superior to placebo for preventing wound infection and intraabdominal abscess, with no apparent difference in the nature of the removed appendix. Studies exclusively on children and studies examining topical application reported results in favour to the above, although the results were not significant. AUTHORS' CONCLUSIONS: Antibiotic prophylaxis is effective in the prevention of postoperative complications in appendectomised patients, whether the administration is given pre-, peri- or post-operatively, and could be considered for routine in emergency appendectomies.


Subject(s)
Abdominal Abscess/prevention & control , Antibiotic Prophylaxis , Appendectomy/adverse effects , Postoperative Complications/prevention & control , Adult , Appendicitis/surgery , Child , Controlled Clinical Trials as Topic , Humans , Length of Stay , Randomized Controlled Trials as Topic , Surgical Wound Infection/prevention & control
4.
Cochrane Database Syst Rev ; (2): CD001439, 2003.
Article in English | MEDLINE | ID: mdl-12804408

ABSTRACT

BACKGROUND: Appendicitis is the most common cause of acute abdominal pain requiring surgical intervention. The cause of appendicitis is unclear and the mechanism of pathogenesis continues to be debated. Despite improved asepsis and surgical techniques, postoperative complications, such as wound infection and intraabdominal abscess, still account for a significant morbidity. Several studies implicate that postoperative infections are reduced by administration of antimicrobial regimes. OBJECTIVES: The objective of this review is to evaluate the use of antibiotics with placebo or no treatment in patients undergoing appendectomy. Will these patients benefit from antimicrobial prophylaxis? The outcomes are described according to the nature of the appendix, as either simple appendicitis (including the non-infectious stage) and complicated appendicitis. This review do not attempt to compare the effect of different regimens. That clinical question is addressed in another review undertaken by Bleuer 1999. SEARCH STRATEGY: We searched The Cochrane Controlled Trials Register (Cochrane Library 2002 issue 4); Pubmed, Embase and the Cochrane Colorectal Cancer Group Specialised Register (Up to October 2002). In addition we manually searched the reference lists of the primary identified trials. SELECTION CRITERIA: We evaluated Randomised Controlled Trials (RCTs) and Controlled Clinical Trials (CCTs) in which any antibiotic regime were compared to placebo in patients suspected of having appendicitis, and undergoing appendectomy. Both studies on children and adults were reviewed. The outcome measures of the studies were: Wound infection, intra abdominal abscess, length of stay in hospital, and mortality. DATA COLLECTION AND ANALYSIS: Eligibility and trial quality were assessed, recorded and cross-checked by two reviewers. MAIN RESULTS: Forty-five studies including 9576 patients were included in this review. The overall result is that the use of antibiotics is superior to placebo for preventing wound infection and intraabdominal abscess, with no apparent difference in the nature of the removed appendix. Studies exclusively on children and studies examining topical application reported results in favour to the above although the results were not significant. REVIEWER'S CONCLUSIONS: Antibiotic prophylaxis is effective in the prevention of postoperative complications in appendectomised patients, whether the administration is given pre-, peri- or post-operatively, and could be considered for routine in emergency appendectomies.


Subject(s)
Abdominal Abscess/prevention & control , Antibiotic Prophylaxis , Appendectomy/adverse effects , Postoperative Complications/prevention & control , Adult , Appendicitis/surgery , Child , Controlled Clinical Trials as Topic , Humans , Length of Stay , Randomized Controlled Trials as Topic , Surgical Wound Infection/prevention & control
5.
Cochrane Database Syst Rev ; (3): CD001439, 2001.
Article in English | MEDLINE | ID: mdl-11686991

ABSTRACT

BACKGROUND: Appendicitis is the most common cause of acute abdominal pain requiring surgical intervention. The cause of appendicitis is unclear and the mechanism of pathogenesis continues to be debated. Despite improved asepsis and surgical techniques, postoperative complications, such as wound infection and intraabdominal abscess, still account for a significant morbidity. Several studies implicate that postoperative infections are reduced by administration of antimicrobial regimes. OBJECTIVES: The objective of this review is to compare the use of antibiotics with placebo or no treatment in patients undergoing appendectomy. Will these patients benefit from antimicrobial prophylaxis? The outcomes are described according to the nature of the appendix, as either simple appendicitis (including the non-infectious stage) and complicated appendicitis. This review do not attempt to compare the effect of different regimens, a clinical question that is addressed in another review undertaken by this Group (CCCG). SEARCH STRATEGY: We searched The Cochrane Controlled Trials Register (Cochrane Library 2000 issue 4), Medline (January 1966 to September 2000), Embase and the Cochrane Colorectal Cancer Group specialised register (September 2000). In addition we manually searched the reference lists of the primary identified trials. SELECTION CRITERIA: Randomised Controlled Trials (RCT) and Controlled Clinical Trials (CCT) in which any antibiotic regime were compared to placebo in patients suspected of having appendicitis undergoing appendectomy were evaluated. Both studies on children and adults were reviewed. The outcome measures of the studies were either wound infection, intraabdominal abscess, length of stay in hospital or mortality. DATA COLLECTION AND ANALYSIS: Eligibility and trial quality were assessed, recorded and cross-checked by to reviewers. MAIN RESULTS: Forty-four studies including 9298 patients were included in this review. The overall result is that use of antibiotics is superior to placebo for the outcome wound infection and intraabdominal abscess, with no apparant difference in the nature of the removed appendix. Studies exclusively on children and studies examining topical application reported results in favour to the above although the results were not significant. REVIEWER'S CONCLUSIONS: Antibiotic prophylaxis is effective in the prevention of postoperative complications in appendectomised patients, whether the administration are given pre-, per- and post-operatively and could be considered for routine in emergency appendectomies.


Subject(s)
Abdominal Abscess/prevention & control , Antibiotic Prophylaxis , Appendectomy/adverse effects , Postoperative Complications/prevention & control , Adult , Appendicitis/surgery , Child , Controlled Clinical Trials as Topic , Humans , Length of Stay , Randomized Controlled Trials as Topic , Surgical Wound Infection/prevention & control
6.
Cochrane Database Syst Rev ; (2): CD001439, 2001.
Article in English | MEDLINE | ID: mdl-11405988

ABSTRACT

BACKGROUND: Appendicitis is the most common cause of acute abdominal pain requiring surgical intervention. The cause of appendicitis is unclear and the mechanism of pathogenesis continues to be debated. Despite improved asepsis and surgical techniques, postoperative complications, such as wound infection and intraabdominal abscess, still account for a significant morbidity. Several studies implicate that postoperative infections are reduced by administration of antimicrobial regimes. OBJECTIVES: The objective of this review is to compare the use of antibiotics with placebo or no treatment in patients undergoing appendectomy. Will these patients benefit from antimicrobial prophylaxis? The outcomes are described according to the nature of the appendix, as either simple appendicitis (including the non-infectious stage) and complicated appendicitis. This review do not attempt to compare the effect of different regimens, a clinical question that is addressed in another review undertaken by this Group (CCCG). SEARCH STRATEGY: We searched The Cochrane Controlled Trials Register (Cochrane Library 2000 issue 4), Medline (January 1966 to September 2000), Embase and the Cochrane Colorectal Cancer Group specialised register (September 2000). In addition we manually searched the reference lists of the primary identified trials. SELECTION CRITERIA: Randomised Controlled Trials (RCT) and Controlled Clinical Trials (CCT) in which any antibiotic regime were compared to placebo in patients suspected of having appendicitis undergoing appendectomy were evaluated. Both studies on children and adults were reviewed. The outcome measures of the studies were either wound infection, intraabdominal abscess, length of stay in hospital or mortality. DATA COLLECTION AND ANALYSIS: Eligibility and trial quality were assessed, recorded and cross-checked by to reviewers. MAIN RESULTS: Forty-four studies including 9298 patients were included in this review. The overall result is that use of antibiotics is superior to placebo for the outcome wound infection and intraabdominal abscess, with no apparent difference in the nature of the removed appendix. Studies exclusively on children and studies examining topical application reported results in favour to the above although the results were not significant. REVIEWER'S CONCLUSIONS: Antibiotic prophylaxis is effective in the prevention of postoperative complications in appendectomised patients, whether the administration are given pre-, per- and post-operatively and could be considered for routine in emergency appendectomies.


Subject(s)
Abdominal Abscess/prevention & control , Antibiotic Prophylaxis , Appendectomy/adverse effects , Postoperative Complications/prevention & control , Appendicitis/surgery , Controlled Clinical Trials as Topic , Humans , Length of Stay , Randomized Controlled Trials as Topic , Surgical Wound Infection/prevention & control
7.
J Gen Virol ; 81(Pt 12): 2833-41, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11086113

ABSTRACT

Like other members of the genus HANTAVIRUS: in the family BUNYAVIRIDAE:, Puumala virus (PUUV) is thought to be co-evolving with its natural host, the bank vole Clethrionomys glareolus. To gain insight into the evolutionary history of PUUV in northern Europe during the last post-glacial period, we have studied wild-type PUUV strains originating from areas along two postulated immigration routes of bank voles to Fennoscandia. Full-length sequences of the S RNA segment and partial sequences (nt 2168-2569) of the M segment were recovered by RT-PCR directly from bank vole tissues collected at three locations in Russian Karelia and one location in Denmark. Phylogenetic analysis showed that strains from Karelia and Finland belong to the same genetic lineage, supporting the hypothesis that PUUV spread to present Finland via a Karelian land-bridge. The Danish PUUV strains showed no particularly close relatedness to any of the known PUUV strains and formed a distinct phylogenetic lineage on trees calculated for both S and M segment sequences. Although no direct link between the Danish PUUV strains and those of the southern Scandinavian lineage was found, within the S segment of Danish PUUV strains, two regions with higher similarity to either northern Scandinavian or - to a less extent - southern Scandinavian genetic lineages were revealed, suggesting evolutionary connections of their precursors.


Subject(s)
Arvicolinae/virology , Evolution, Molecular , Hantavirus Infections/virology , Orthohantavirus/genetics , Phylogeny , Amino Acid Sequence , Animals , Denmark , Orthohantavirus/chemistry , Orthohantavirus/classification , Hantavirus Infections/veterinary , Molecular Sequence Data , Nucleocapsid/chemistry , Nucleocapsid/genetics , Russia , Sequence Alignment , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics
8.
Ugeskr Laeger ; 162(7): 939-40, 2000 Feb 14.
Article in Danish | MEDLINE | ID: mdl-10740437

ABSTRACT

A mammographic pitfall is presented. After lumpectomy owing to cancer in the breast a woman developed an immediate allergic reaction presumably caused by the subcutaneous sutures (vicryl). After adjuvant irradiation the breast became swollen and mammography gave suspicion of a recurrent breast cancer. Surgical excision was performed and examination of the biopsy specimen showed a foreign body reaction to the suture material with fibrosis and eosinophilia.


Subject(s)
Foreign-Body Reaction , Mammography , Sutures/adverse effects , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/surgery , False Positive Reactions , Female , Foreign-Body Reaction/etiology , Foreign-Body Reaction/pathology , Foreign-Body Reaction/surgery , Humans , Middle Aged
9.
Transplantation ; 67(9): 1209-14, 1999 May 15.
Article in English | MEDLINE | ID: mdl-10342310

ABSTRACT

BACKGROUND: A widely held view is that any increase in the potency of an immunosuppressive agent will lead to an increase in infection and malignancy, such as life-threatening Epstein-Barr virus (EBV) induced posttransplant lymphoproliferative disorders (PTLD). We tested this paradigm by studying the effect of adding mofetil to a steroid-free protocol under cover of high-dose aciclovir prophylaxis on the number of acute rejections, EBV infections and PTLDs after kidney transplantation. METHODS: EBV serology was performed in 267 consecutive renal transplantations (1990-1997). All were treated with cyclosporine with an initial 10-day antilymphocyte globulin course, supplemented from September 1995 with MMF. In 208 consecutive transplantations after June 1992 aciclovir 3200 mg/day was given for 3 months posttransplantation. RESULTS: After an observation period of up to 7 years we found that: (1) primary or reactivated EBV infection (PREBV) was correlated to acute rejection (treated with OKT3; P<0.00005) and to the incidence of PTLD (P=0.03; P=0.01, if Hodgkin's disease is included); (2) aciclovir protected against PREBV (P<0.00005) and (3) adding mofetil to the immunosuppressive protocol reduced PREBV further (P=0.0001), (4) in 78 transplantations treated with cyclosporine/antilymphocyte globulin/mofetil we observed only 10 acute rejections (P=0.0001), 10 PREBVs (P<0.00005), and no PTLDs compared with the cyclosporine/antilymphocyte globulin group (P=0.04). CONCLUSIONS: Supplemental immunosuppression with mofetil protects against acute rejection. In combination with aciclovir, there is also a reduction in the number of PREBVs, apparently as a result of both direct viral prophylaxis and better rejection control, and in the incidence of EBV-induced PTLD.


Subject(s)
Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , Graft Rejection/prevention & control , Herpesviridae Infections/prevention & control , Herpesvirus 4, Human/drug effects , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/adverse effects , Kidney Transplantation/immunology , Lymphoproliferative Disorders/prevention & control , Mycophenolic Acid/analogs & derivatives , Acute Disease , Adolescent , Adult , Antilymphocyte Serum/therapeutic use , Child , Female , Graft Rejection/epidemiology , Herpesviridae Infections/blood , Herpesviridae Infections/epidemiology , Humans , Incidence , Lymphoproliferative Disorders/epidemiology , Lymphoproliferative Disorders/etiology , Male , Middle Aged , Muromonab-CD3/therapeutic use , Mycophenolic Acid/therapeutic use , Prospective Studies , Retrospective Studies
10.
Transplantation ; 67(6): 876-81, 1999 Mar 27.
Article in English | MEDLINE | ID: mdl-10199737

ABSTRACT

BACKGROUND: Posttransplant lymphoproliferative disorder (PTLD) is a life-threatening complication of transplantation, which comprises a morphologically and clinically heterogeneous spectrum of B-lymphocyte diseases. Risk factors include primary or reactivated Epstein-Barr virus (EBV) infection, and the type and duration of immunosuppression. Interleukin-10 (IL-10) is a pleiotropic cytokine, produced primarily by T-helper 2 (Th2) lymphocytes in the later stages of T-cell activation, suggested to play a role in EBV-associated PTLD. We recently reported preliminary findings on IL-10 in relation to the development of PTLD in three kidney transplanted patients. The study now includes nine patients that could be followed before and/or after the occurrence of lymphoma. METHODS: Nine patients with lymphomas (eight PTLDs and one Hodgkin's disease) were diagnosed among 268 consecutive renal transplantations (1990-1997). All were treated with cyclosporine with an initial 10-day course of antilymphocyte globulin, supplemented from 1995 with mycophenolate mofetil. Serum antibodies against EBV were detected using recombinant antigens. A double sandwich enzyme-linked immunosorbent assay using rabbit antibodies to purified human recombinant IL-10 was employed; the assay is specific for human natural and viral IL-10. RESULTS: Three patients experienced primary EBV infection, five reactivated EBV infections, and one did not change EBV status. Three patients had a fulminant course and died with EBV-associated PTLD confirmed post mortem. The other six are alive and are apparently cured. Treatment was immediate discontinuation of immunosuppression (in all PTLDs) and long-term high-dose aciclovir in all but one. Two patients have maintained excellent graft function for 3 and 2 years, respectively, without immunosuppression and are now in a state of operational tolerance. In three of four cases with initial lymphoma, EBV infection (primary or reactivation) preceded the increase in IL-10. In all four cases, the IL-10 increase preceded the PTLD diagnosis. In six cases, IL-10 could be followed after treatment showing either immediate zero or a decrease to zero. CONCLUSION: IL-10 seems to play a role in EBV-associated PTLD. Moreover, IL-10 may have an important role in transplant tolerance by inducing long-lasting anergy to donor- and host-specific alloantigens, perhaps caused by down-regulation of Th1 cytokines in the graft. If substantiated, this may provide new insight into the pathogenesis of PTLD introducing new strategies for prevention and therapy of PTLD, and for the induction of tolerance in transplanted patients.


Subject(s)
Interleukin-10/physiology , Kidney Transplantation/adverse effects , Lymphoproliferative Disorders/etiology , Acyclovir/therapeutic use , Adult , Animals , Child , Female , Herpesviridae Infections/complications , Herpesvirus 4, Human , Humans , Male , Middle Aged , Rabbits , Tumor Virus Infections/complications
11.
Article in English | MEDLINE | ID: mdl-10052374

ABSTRACT

OBJECTIVE: It has been demonstrated that contamination of the insides of high-speed dental turbines occurs and that bacteria as well as viruses may remain infectious when expelled from such turbines during subsequent use. Consequently, it has been widely recommended that a high-speed turbine be sterilized after each patient. The purpose of this study was to evaluate the effect of steam autoclaving on a high-speed dental turbine with a contaminated turbine chamber. STUDY DESIGN: Streptococcus salivarius and endospores of Bacillus stearothermophilus were used as test organisms to determine the effectiveness of 4 different small non-vacuum autoclaves and one vacuum autoclave. RESULTS: The study demonstrated different efficiencies among the small non-vacuum autoclaves, the best showing close to a 6 log reduction of the test organisms inside the turbine chamber. When cleaning and lubrication of the high-speed dental turbine was carried out before autoclaving, this level of reduction was observed for all the examined non-vacuum autoclaves. CONCLUSIONS: It is concluded that cleaning before sterilization is essential for safe use of high-speed dental turbines and that small non-vacuum autoclaves should be carefully evaluated before being used for the reprocessing of hollow instruments such as high-speed turbines.


Subject(s)
Dental High-Speed Equipment/microbiology , Infection Control, Dental/methods , Sterilization/methods , Equipment Contamination/prevention & control , Geobacillus stearothermophilus/isolation & purification , Humans , Infection Control, Dental/instrumentation , Saliva/microbiology , Spores, Bacterial/isolation & purification , Steam , Sterilization/instrumentation , Streptococcus/isolation & purification , Vacuum
12.
Ugeskr Laeger ; 161(6): 794-6, 1999 Feb 08.
Article in Danish | MEDLINE | ID: mdl-10068350

ABSTRACT

Complications in two varicella zoster virus (VZV) vaccinated children with leukemia in remission are reported. Case I presented with varicella on day 30 after vaccination, with a relapse on day 49 and development of zoster on day 70. VZV was detected in vesicles by PCR on days 49 and 70. Case II presented with varicella on day 32 after vaccination, and VZV was detected in vesicles and nasal secretion. The manifestations were mild and responded to treatment. PCR methods were directed toward the R5 and PS regions. The virus from the two children was unambiguously identified as the Oka vaccine strain. The majority of Danish field strains had only one copy of the 112 basepair repeat element in the R5 region, but two, four and presumably higher copy numbers were also seen. All Danish field strains had the Pst1 cleavage site in the PS region.


Subject(s)
Chickenpox Vaccine/adverse effects , Chickenpox/etiology , Herpes Zoster/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Chickenpox/immunology , Child, Preschool , Female , Herpes Zoster/immunology , Herpesvirus 3, Human/genetics , Herpesvirus 3, Human/immunology , Herpesvirus 3, Human/isolation & purification , Humans , Immunocompromised Host , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Vaccines, Attenuated/adverse effects
13.
Scand J Infect Dis ; 30(3): 221-6, 1998.
Article in English | MEDLINE | ID: mdl-9790127

ABSTRACT

METHOD: Since 1990, we have treated all kidney transplanted patients with cyclosporin (CsA)+ an initial 10 d antilymphocyte globulin (ALG) course, from September 1995 supplemented with mycophenolate mofetil (MMF). In 170 consecutive transplantations from June 1992 to the end of 1996, aciclovir 3200 mg/d (adjusted for kidney function and in children to age) was given prophylactically for 3 months post-transplantation (Tx), monitored with systematic and frequent tests for HSV and CMV. In case of CMV infection, we gave ganciclovir intravenously (oral ganciclovir from 1996) in doses according to kidney function for 3 months, followed by a further 3 months observation and monitoring period. In case of acute cellular rejection, ganciclovir was given during the 10-d OKT3 course and 1 week further. In case of delayed graft function combined with aciclovir side effects, ganciclovir was given until aciclovir could be reintroduced. RESULTS: 39% were HSV seronegative at Tx. There were no seroconversions or reactivations within the observation period. No mucocutaneous HSV infections was observed. No resistant strains developed. 26% were both HSV and CMV negative at Tx. 52% were CMV negative at Tx. 30% experienced a CMV infection post-transplant. The patients were grouped according to CMV status in the donor (D) and recipient (R) before Tx. We found approximately the same number of patients in the 4 CMV groups D-/R-, D+/R-, D-/R+ and D+/R+. Most infections occurred in the D+/R- group compared to D-/R- (p = 0.009). A significant increase in the number of CMV infections occurred in this subgroup when we gave reduced doses in case of delayed graft function (p = 0.015), from 1994. We observed only 1 CMV disease (in 1992). Serological EBV testing were performed concomitantly. No correlation was seen between CMV and EBV infections. From September 1995 we have treated all transplanted patients (n = 40) with CsA/ALG/MMF. We found no significant increase in CMV infections in this group. CONCLUSIONS: Prophylaxis with aciclovir (combined with ganciclovir during acute rejections and in case of delayed graft function with aciclovir side effects) gives a good protection against HSV and CMV infections and prevents CMV disease effectively. High-dose aciclovir post-transplantation (or shift to ganciclovir) seems to be important to obtain effective prophylaxis. Better immunosuppression with MMF does not result in more CMV infections.


Subject(s)
Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , Ganciclovir/therapeutic use , Herpesviridae Infections/prevention & control , Kidney Transplantation , Opportunistic Infections/prevention & control , Antigens, Viral/analysis , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/prevention & control , Epstein-Barr Virus Infections/diagnosis , Epstein-Barr Virus Infections/prevention & control , Herpesviridae Infections/diagnosis , Humans , Immunocompromised Host , Kidney Transplantation/immunology , Opportunistic Infections/diagnosis
14.
Article in English | MEDLINE | ID: mdl-9394384

ABSTRACT

Dental high-speed turbines and handpieces can take up and expel microorganisms during operation and thus need regular sterilization. This study established a method for validating devices used to sterilize high-speed turbines and handpieces. The air and water channels and turbine chambers were contaminated with suspensions of Streptococcus salivarius or endospores of Bacillus stearothermophilus. The effect of flushing and/or autoclaving performed by a new device combining both procedures was evaluated by counting the number of viable bacteria recovered from these devices. Further, the effect on clinically used handpieces was evaluated. In an initial experiment, the device partially reduced S. salivarius, and the endospores survived. In a second experiment, a 5 to 6 log reduction of S. salivarius in air and water channels was obtained. No growth was observed in clinically used high-speed handpieces, and both S. salivarius and endospores were eliminated from the turbine chambers. Thus, the method of validation proved capable of discriminating between different levels of bacterial reduction.


Subject(s)
Dental High-Speed Equipment , Sterilization/instrumentation , Air , Colony Count, Microbial , Equipment Contamination/prevention & control , Equipment Design , Evaluation Studies as Topic , Geobacillus stearothermophilus/growth & development , Hot Temperature , Humans , Reproducibility of Results , Spores, Bacterial/growth & development , Streptococcus/growth & development , Surface Properties , Vacuum , Water
15.
Pflugers Arch ; 431(1): 52-65, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8584418

ABSTRACT

With the single-channel patch-clamp technique we have identified Ca2+-sensitive, high-conductance (maxi) K+ channels in the basolateral membrane (BLM) of exocrine gland cells in frog skin. Under resting conditions, maxi K+ channels were normally quiescent, but they were activated by muscarinic agonists or by high serosal K+. In excised inside-out patches and with symmetrical 140mmol/l K+, single-channel conductance was 200pS and the channel exhibited a high selectivity for K+ over Na+. Depolarization of the BLM increased maxi K+ channel activity. Increasing cytosolic free Ca2+ (by addition of 100nmol/l thapsigargin to the bathing solution of cell-attached patches also increased channel activity, whereas thapsigargin had no effect when added to excised inside-out patches. An increase in cytosolic free Ca2+ directly activated channel activity in a voltage-dependent manner. Maxi K+ channel activity was sensitive to changes in intracellular pH, with maximal activity at pH 7.4 and decreasing activities following acidification and alkalinization. Maxi K+ channel outward current was reversibly blocked by micromolar concentrations of Ba2+ from the cytosolic and extracellular site, and was irreversibly blocked by micromolar concentrations of charybdotoxin and kaliotoxin from the extracellular site in outside-out patches.


Subject(s)
Calcium/physiology , Exocrine Glands/metabolism , Potassium Channels/metabolism , Skin/metabolism , Animals , Barium/pharmacology , Cytosol/drug effects , Cytosol/metabolism , Enzyme Inhibitors/pharmacology , Exocrine Glands/cytology , Exocrine Glands/drug effects , Extracellular Space/drug effects , Extracellular Space/metabolism , Hydrogen-Ion Concentration , In Vitro Techniques , Ion Channel Gating/drug effects , Ion Channel Gating/physiology , Potassium Channels/drug effects , Rana esculenta , Skin/cytology , Skin/drug effects , Terpenes/pharmacology , Thapsigargin
16.
APMIS ; 103(6): 416-8, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7546643

ABSTRACT

The Abbott TestPack RSV was compared with an in-house RSV enzyme-linked immunosorbent assay (ELISA) for detection of respiratory syncytial virus (RSV) antigen. Nasopharyngeal specimens were obtained from 121 inpatients. RSV antigen was detected in 46 specimens by the Abbott TestPack, 42 of these being confirmed by the in-house RSV ELISA. Of the 75 specimens tested negative in the Abbott TestPack RSV, one was found positive by the in-house RSV ELISA. The sensitivity and specificity of the Abbott TestPack RSV versus the RSV ELISA were 98% and 95% respectively.


Subject(s)
Nasopharynx/virology , Respiratory Syncytial Virus Infections/diagnosis , Respiratory Syncytial Virus, Human/isolation & purification , Antigens, Viral/analysis , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant , Male , Respiratory Syncytial Virus, Human/immunology , Sensitivity and Specificity
17.
Zentralbl Hyg Umweltmed ; 196(5): 437-43, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7727023

ABSTRACT

This study deals with the decontamination of dental turbines and handpieces (DTH) aiming at eliminating the cross-infection risk in dental practice. Three types of equipment designed for cleaning/lubricating DTH were validated. The effect of the three devices was determined for four different types of DTH, which were artificially contaminated with Streptococcus salivarius ATCC 13419 in a controlled manner. Sampling was carried out by collecting one ml water flushed through the DTH connected to a dental unit. The study resulted in a model for testing the decontamination potential of a cleaning/lubrication device for DTH. One of the devices could not reduce the contamination, while two others were able to reduce the bioburden with at least 3.9 logarithmic steps. However none of the devices tested could constantly eliminate the contamination, for which reason an additional heat treatment of the DTH is recommended.


Subject(s)
Decontamination/methods , Dental Equipment/standards , Disinfection/methods , Alcohols , Cross Infection/epidemiology , Cross Infection/prevention & control , Humans , Lubrication , Risk Factors
18.
Scand J Infect Dis ; 27(3): 245-51, 1995.
Article in English | MEDLINE | ID: mdl-8539549

ABSTRACT

In the 25-year period 1968-92, 3,317 out of 477,420 patients admitted to Frederiksberg Hospital experienced 3,491 episodes of bacteremia. Enterobacteriaceae dominated as causative agents (57%), following by Gram-positive cocci (31%) and anaerobes (7%). Polymicrobial bacteremia was found in 8% of the episodes. The incidence of Enterobacteriaceae bacteremia culminated in the middle (1978-82) of the period (4.7/1,000 admissions) and decreased during the last decade. Gram-positive bacteremia increased throughout the period (from 1.8 to 2.9; p < 0.001), due mainly to increasing incidences of bacteremia caused by non-hemolytic streptococci, Streptococcus pneumoniae and coagulase-negative staphylococci. Bacteroides fragilis accounted for a rising incidence of anaerobic bacteremia (from 0.3 to 0.7; p < 0.05). Clinical data were available for the 2,599 bacteremic episodes in the 20-year period 1968-87. 59% of these were hospital acquired. Of those, 38% were associated with indwelling catheters, mainly bladder catheters (28%) and i.v. lines (7%). The urinary tract dominated as source of bacteremia (46%), followed by the respiratory (11%) and the gastrointestinal tract (9%). Half of the patients had predisposing underlying diseases, most frequently malignancies (20%) and diabetes mellitus (7%). The mortality rate related to bacteremia decreased from 25% to 11% (p < 0.001). More than half (55%) of the fatal cases related to bacteremia occurred within the first 2 days after the first positive blood culture was obtained. Logistic regression analysis defined 7 variables that independently influenced the outcome related to bacteremia: age, source, culture verification of source, shock, body temperature, leukocyte count and empiric antibiotic treatment.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Bacteremia/epidemiology , Hospitals, University , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/microbiology , Bacteria/isolation & purification , Community-Acquired Infections/drug therapy , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Denmark/epidemiology , Female , Hospitals, University/trends , Humans , Incidence , Male , Middle Aged , Risk Factors
19.
Ugeskr Laeger ; 157(5): 586-90, 1995 Jan 30.
Article in Danish | MEDLINE | ID: mdl-7638914

ABSTRACT

Hitherto, nosocomial epidemic outbreaks of legionnaire's disease have not been reported in Denmark. Only sporadic cases have been described. A survey of 75 Danish hospitals concerning the dimensions and operation of the hot-water systems revealed that only 13% had a hot water tank temperature above the recommended 60 degrees C. Temperatures of coldest tap water and of returning water were above 50 degrees C in only 31% and 24% respectively. Twelve representative hospitals with 35 independent water systems were investigated for the presence of Legionella pneumophila (Lp). Lp was demonstrated in all the hospitals and in 34 (97%) of the systems. The prevailing serogroups were (in order of frequency) 3, 1, 2, 5 and 6. We conclude that the operation of the hot tap water systems should be optimized. This report indicates that nosocomial epidemics are conceivable and attention should be paid to the disease as a diagnostic possibility in patients with primary atypical pneumonia.


Subject(s)
Legionella pneumophila/isolation & purification , Maintenance , Water Microbiology , Cross Infection/prevention & control , Denmark , Humans , Hygiene , Legionnaires' Disease/prevention & control , Surveys and Questionnaires , Temperature , Water Supply , Workforce
20.
Ugeskr Laeger ; 156(34): 4817, 4820-3, 1994 Aug 22.
Article in Danish | MEDLINE | ID: mdl-7992416

ABSTRACT

An epidemiological study of Legionnaires' disease in Denmark is presented. A high incidence of apparently sporadic cases of Legionnaires' disease in Denmark was found. The source of infection remains obscure in most cases. No outbreaks have been registered in Denmark, in contrast to most European countries. It is concluded that intensified surveillance, including monitoring of water distribution systems in hospitals, combined with an earlier etiological diagnosis might disclose more nosocomial cases.


Subject(s)
Legionnaires' Disease/epidemiology , Denmark/epidemiology , Europe/epidemiology , Humans , Incidence , Legionnaires' Disease/diagnosis , Legionnaires' Disease/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...